Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CIK cell infusion plus best supportive care in advanced primary lung cancer
ChiCTR-TRC-11001558Phase 2Completed
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Sep 2011
- Modality
- CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, TCR-Engineered T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in bronchial carcinoma comparing Autologous CIK cells + best supportive care with Best supportive care (2 arms). Primary endpoints: Disease control rate, Progression-free survival and 1 more. Started Sep 2011; status: completed.
02
Drugs
autologous cytokine-induced killer cells
03
Conditions
bronchial carcinoma
Beyond the preview
Go deeper on ChiCTR-TRC-11001558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-11001558.